Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Alpha-1 Antitrypsin Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Alpha-1 Antitrypsin Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Alpha-1 Antitrypsin Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Alpha-1 Antitrypsin Drugs Supply by Company

    • 2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume by Company
    • 2.2 Global Alpha-1 Antitrypsin Drugs Sales Value by Company
    • 2.3 Global Alpha-1 Antitrypsin Drugs Price by Company
    • 2.4 Alpha-1 Antitrypsin Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Alpha-1 Antitrypsin Drugs Market Status by Category

    • 3.1 Alpha-1 Antitrypsin Drugs Category Introduction
      • 3.1.1 Parenteral
      • 3.1.2 Inhalation
    • 3.2 Global Alpha-1 Antitrypsin Drugs Market by Category
      • 3.2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Alpha-1 Antitrypsin Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Alpha-1 Antitrypsin Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Alpha-1 Antitrypsin Drugs Market Status by End User/Segment

    • 4.1 Alpha-1 Antitrypsin Drugs Segment by End User/Segment
      • 4.1.1 Drugstore
      • 4.1.2 Hospital
      • 4.1.3 Others
    • 4.2 Global Alpha-1 Antitrypsin Drugs Market by End User/Segment
      • 4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Alpha-1 Antitrypsin Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Alpha-1 Antitrypsin Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Alpha-1 Antitrypsin Drugs Market Status by Region

    • 5.1 Global Alpha-1 Antitrypsin Drugs Market by Region
      • 5.1.1 Global Alpha-1 Antitrypsin Drugs Sales Volume by Region
      • 5.1.2 Global Alpha-1 Antitrypsin Drugs Sales Value by Region
    • 5.2 North America Alpha-1 Antitrypsin Drugs Market Status
    • 5.3 Europe Alpha-1 Antitrypsin Drugs Market Status
    • 5.4 Asia Pacific Alpha-1 Antitrypsin Drugs Market Status
    • 5.5 Central & South America Alpha-1 Antitrypsin Drugs Market Status
    • 5.6 Middle East & Africa Alpha-1 Antitrypsin Drugs Market Status

    6 North America Alpha-1 Antitrypsin Drugs Market Status

    • 6.1 North America Alpha-1 Antitrypsin Drugs Market by Country
      • 6.1.1 North America Alpha-1 Antitrypsin Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Alpha-1 Antitrypsin Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Alpha-1 Antitrypsin Drugs Market Status

    • 7.1 Europe Alpha-1 Antitrypsin Drugs Market by Country
      • 7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Alpha-1 Antitrypsin Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Alpha-1 Antitrypsin Drugs Market Status

    • 8.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market by Country
      • 8.1.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Alpha-1 Antitrypsin Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Alpha-1 Antitrypsin Drugs Market Status

    • 9.1 Central & South America Alpha-1 Antitrypsin Drugs Market by Country
      • 9.1.1 Central & South America Alpha-1 Antitrypsin Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Alpha-1 Antitrypsin Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Alpha-1 Antitrypsin Drugs Market Status

    • 10.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Market by Country
      • 10.1.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Alpha-1 Antitrypsin Drugs Manufacturing Cost Analysis
    • 11.5 Alpha-1 Antitrypsin Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Alpha-1 Antitrypsin Drugs Sales Channel
      • 11.5.2 Alpha-1 Antitrypsin Drugs Distributors
    • 11.6 Alpha-1 Antitrypsin Drugs Downstream Major Buyers

    12 Global Alpha-1 Antitrypsin Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Alpha-1 Antitrypsin Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Alpha-1 Antitrypsin Drugs Forecast by Category
      • 12.2.1 Global Alpha-1 Antitrypsin Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Alpha-1 Antitrypsin Drugs Sales Value Forecast by Category
      • 12.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Category
    • 12.3 Global Alpha-1 Antitrypsin Drugs Forecast by End User/Segment
      • 12.3.1 Global Alpha-1 Antitrypsin Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Alpha-1 Antitrypsin Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by End User/Segment

    13 Global Alpha-1 Antitrypsin Drugs Market Forecast by Region/Country

    • 13.1 Global Alpha-1 Antitrypsin Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Alpha-1 Antitrypsin Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Alpha-1 Antitrypsin Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Kamada
      • 14.1.1 Company Information
      • 14.1.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.1.3 Kamada Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Grifols
      • 14.2.1 Company Information
      • 14.2.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.2.3 Grifols Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 CSL Behring
      • 14.3.1 Company Information
      • 14.3.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.3.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Baxter
      • 14.4.1 Company Information
      • 14.4.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.4.3 Baxter Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Baxalta
      • 14.5.1 Company Information
      • 14.5.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.5.3 Baxalta Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Arrowhead Research Corporation
      • 14.6.1 Company Information
      • 14.6.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.6.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Applied Genetic Technologies Corp
      • 14.7.1 Company Information
      • 14.7.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Alnylam Pharmaceuticals
      • 14.8.1 Company Information
      • 14.8.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.8.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Abeona Therapeutics
      • 14.9.1 Company Information
      • 14.9.2 Alpha-1 Antitrypsin Drugs Product Introduction
      • 14.9.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Alpha-1 Antitrypsin Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Alpha-1 Antitrypsin Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Parenteral
      Inhalation

      Segmented by End User/Segment
      Drugstore
      Hospital
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Kamada
      Grifols
      CSL Behring
      Baxter
      Baxalta
      Arrowhead Research Corporation
      Applied Genetic Technologies Corp
      Alnylam Pharmaceuticals
      Abeona Therapeutics
      Buy now